Stephens analyst Brett Huff lowered his price target for Equifax to $133 from $140 on valuation. The analyst notes that Equifax is down second-most of his processing stocks since the election and thinks the Street has lost sight of potential 2017 out-performance. He reiterates an Overweight rating on the shares.

Redburn Atlantic lowered the firm's price target on Equifax to $274 from $278 and keeps a Neutral rating on the shares. The analyst anticipates strong revenue and earnings growth at Equifax over the next five years, but says the company's valuation already adequately reflects this positive outlook for growth.

Citi analyst Arthur Truslove opened a "30-day positive catalyst watch" on shares of Equifax ahead of the company's Q4 results on April 17. Management has guided on the basis of mortgage enquiry volumes down 26% in Q1, but Citi's data suggests mortgage applications are down 13%, while mortgage originations may actually be up, the analyst tells investors in a research note. The firm believes the consensus underappreciates the impact on Equifax's adjusted EBITDA arising from a rebound in the U.S. mortgage market. The firm keeps a Buy rating on the shares with a $035 price target.